CENTAUR PHARMACEUTICALS PVT LTD

CENTAUR PHARMACEUTICALS PVT LTD (India) holds 25 active US FDA Type II Drug Master Files and 2 inactive, has DMF or CEP filings on record for 30 active ingredients and is linked to 3 FDA-registered manufacturing sites. 4 FDA enforcement records are linked to it.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “CENTAUR PHARMACEUTICALS PVT LTD: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/centaur-pharmaceuticals-pvt-ltd

Overview

CENTAUR PHARMACEUTICALS PVT LTD is an active pharmaceutical ingredient (API) supplier with 34 active FDA Type II Drug Master Files, covering ALPRAZOLAM USP; AZITHROMYCIN DIHYDRATE USP; BRIMONIDINE TARTRATE USP; CHLORDIAZEPOXIDE HCL USP; CHLORDIAZEPOXIDE USP; CHLORZOXAZONE USP.

Core services & business areas

API Manufacturing

Active ingredients with DMF or CEP filings

Substances for which CENTAUR PHARMACEUTICALS PVT LTD holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.

API / Drug Master Files

CENTAUR PHARMACEUTICALS PVT LTD holds 25 active (27 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • LINAGLIPTINActive2022-05-30
  • VARENICLINE TARTRATEActive2022-03-30
  • FLUPHENAZINE HYDROCHLORIDE USPActive2021-09-23
  • TRIAZOLAM USPActive2021-05-17
  • CHLORDIAZEPOXIDE HCL USPActive2021-03-25
  • CHLORZOXAZONE USPActive2017-09-29
  • LEVOMILNACIPRAN HYDROCHLORIDEActive2017-04-28
  • PINDOLOL USPActive2017-04-07
  • ZOLPIDEM TARTRATE USPActive2016-08-12
  • METOLAZONE USPActive2016-03-21
  • LOXAPINE SUCCINATE USPActive2015-11-06
  • CLOBAZAM USPActive2015-05-29
  • ZALEPLON USPActive2013-09-25
  • MILNACIPRAN HYDROCHLORIDEActive2012-12-03
  • TETRABENAZINEActive2012-08-03
  • ES-ZOPICLONE USPActive2012-06-07
  • CHLORDIAZEPOXIDE USPActive2011-09-29
  • BRIMONIDINE TARTRATE USPActive2010-06-09
  • TIMOLOL MALEATE USPActive2010-03-11
  • CLONAZEPAM USPActive2009-02-17
  • LORAZEPAM USPActive2009-01-23
  • OXAZEPAM USPActive2008-09-30
  • DIAZEPAM USPActive2008-07-24
  • ZOPICLONEActive2007-11-15
  • ALPRAZOLAM USPActive2007-08-30
  • NORTRIPTYLINE HCI USPInactive2011-10-07
  • TEMAZEPAM USPInactive2011-10-03

Registered manufacturing sites (3)

Physical sites registered with the US FDA and resolved to CENTAUR PHARMACEUTICALS PVT LTD, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.

FDA compliance signals

4 FDA enforcement records linked to this company.

  • warning_letter2023-07-25

    FDA Warning Letter (drug product)

  • warning_letter2023-06-05

    FDA Warning Letter (drug product)

  • 4832016-11-14

    Written program not followed

  • 4832016-11-14

    Establishment of time limitations

For suppliers

Is this CENTAUR PHARMACEUTICALS PVT LTD?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.